DK0501678T3 - Behandling af okulær hypertension med en synergistisk kombination - Google Patents

Behandling af okulær hypertension med en synergistisk kombination

Info

Publication number
DK0501678T3
DK0501678T3 DK92301412.0T DK92301412T DK0501678T3 DK 0501678 T3 DK0501678 T3 DK 0501678T3 DK 92301412 T DK92301412 T DK 92301412T DK 0501678 T3 DK0501678 T3 DK 0501678T3
Authority
DK
Denmark
Prior art keywords
treatment
ocular hypertension
synergistic combination
pharmaceutically acceptable
ketoprostaglandin
Prior art date
Application number
DK92301412.0T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0501678T3 publication Critical patent/DK0501678T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92301412.0T 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination DK0501678T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6132891 1991-03-01

Publications (1)

Publication Number Publication Date
DK0501678T3 true DK0501678T3 (da) 1996-05-28

Family

ID=13167964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92301412.0T DK0501678T3 (da) 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination

Country Status (11)

Country Link
US (1) US5547968A (cg-RX-API-DMAC7.html)
EP (1) EP0501678B1 (cg-RX-API-DMAC7.html)
JP (1) JP2511611B2 (cg-RX-API-DMAC7.html)
KR (1) KR100221369B1 (cg-RX-API-DMAC7.html)
AT (1) ATE137407T1 (cg-RX-API-DMAC7.html)
CA (1) CA2061907C (cg-RX-API-DMAC7.html)
DE (1) DE69210286T2 (cg-RX-API-DMAC7.html)
DK (1) DK0501678T3 (cg-RX-API-DMAC7.html)
ES (1) ES2089387T3 (cg-RX-API-DMAC7.html)
GR (1) GR3019820T3 (cg-RX-API-DMAC7.html)
TW (1) TW210287B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270349A1 (en) * 1996-11-01 1998-05-14 Jesse A. May Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
CA3099517C (en) * 2012-07-13 2022-04-26 Santen Pharmaceutical Co., Ltd. Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
EP0455264B1 (en) * 1987-09-18 1994-07-13 R-Tech Ueno Ltd. Ocular hypotensive agents
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
DE68928551T2 (de) * 1988-10-01 1998-04-23 Ueno Seiyaku Oyo Kenkyujo Kk Oculare hypotensive Mittel

Also Published As

Publication number Publication date
GR3019820T3 (en) 1996-08-31
ATE137407T1 (de) 1996-05-15
EP0501678A2 (en) 1992-09-02
ES2089387T3 (es) 1996-10-01
US5547968A (en) 1996-08-20
JP2511611B2 (ja) 1996-07-03
DE69210286D1 (de) 1996-06-05
TW210287B (cg-RX-API-DMAC7.html) 1993-08-01
DE69210286T2 (de) 1996-09-12
JPH0565227A (ja) 1993-03-19
CA2061907C (en) 2003-04-08
KR100221369B1 (ko) 1999-09-15
EP0501678B1 (en) 1996-05-01
KR920017654A (ko) 1992-10-21
EP0501678A3 (en) 1992-12-16
CA2061907A1 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
MX9204381A (es) Metodo para tratar inflamacion ocular
ATE175875T1 (de) Tirilazad parentale formulierung mit einem co- lösungsmittel
DE69212203D1 (de) Intrakorporale injizierbare Zusammensetzung zum Implantieren von hochkonzentriertem vernetzten Atelokollagen
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
FI932254A7 (fi) Menetelmä dipalmitoyylifosfaridyylikoliinidispersioiden antamiseksi
DK0735868T3 (da) Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul
DK0459666T3 (da) Lægemidler mod impotens
DK0501678T3 (da) Behandling af okulær hypertension med en synergistisk kombination
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
DK0662325T3 (da) Inhibering af ovariedysgenese, forsinket pubertet eller sexuel infantilisme
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DE69208759D1 (de) Salze von N-Nitrosophenylhydroxylamin
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
DK0740657T3 (da) 4-Arylisoindoler med analgetisk virkning
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis